eLife (Apr 2021)

Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition

  • Zachariah Bertels,
  • Harinder Singh,
  • Isaac Dripps,
  • Kendra Siegersma,
  • Alycia F Tipton,
  • Wiktor D Witkowski,
  • Zoie Sheets,
  • Pal Shah,
  • Catherine Conway,
  • Elizaveta Mangutov,
  • Mei Ao,
  • Valentina Petukhova,
  • Bhargava Karumudi,
  • Pavel A Petukhov,
  • Serapio M Baca,
  • Mark M Rasenick,
  • Amynah A Pradhan

DOI
https://doi.org/10.7554/eLife.63076
Journal volume & issue
Vol. 10

Abstract

Read online

Migraine is the sixth most prevalent disease worldwide but the mechanisms that underlie migraine chronicity are poorly understood. Cytoskeletal flexibility is fundamental to neuronal-plasticity and is dependent on dynamic microtubules. Histone-deacetylase-6 (HDAC6) decreases microtubule dynamics by deacetylating its primary substrate, α-tubulin. We use validated mouse models of migraine to show that HDAC6-inhibition is a promising migraine treatment and reveal an undiscovered cytoarchitectural basis for migraine chronicity. The human migraine trigger, nitroglycerin, produced chronic migraine-associated pain and decreased neurite growth in headache-processing regions, which were reversed by HDAC6 inhibition. Cortical spreading depression (CSD), a physiological correlate of migraine aura, also decreased cortical neurite growth, while HDAC6-inhibitor restored neuronal complexity and decreased CSD. Importantly, a calcitonin gene-related peptide receptor antagonist also restored blunted neuronal complexity induced by nitroglycerin. Our results demonstrate that disruptions in neuronal cytoarchitecture are a feature of chronic migraine, and effective migraine therapies might include agents that restore microtubule/neuronal plasticity.

Keywords